The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vancomycin     Quarter: 2016Q3

Total Records: 1,050     Number of Pages: 53

DRUGNAME PT EventCount
Vancomycin (Unknown) Rash erythematous 1
Vancomycin (Unknown) Septic shock 1
Vancomycin (Unknown) Transaminases increased 1
Vancomycin (Unknown) Tubulointerstitial nephritis 1
Vancomycin (Unknown) Type IV hypersensitivity reaction 1
VANCOMYCIN 1 GM FRESENIUS KABI USA Dizziness 1
VANCOMYCIN 1 GM FRESENIUS KABI USA Eye pain 1
VANCOMYCIN 1 GM FRESENIUS KABI USA Hypoacusis 1
VANCOMYCIN 1 GM FRESENIUS KABI USA Nausea 1
VANCOMYCIN 1 GRAM FRESENIUS KABI USA Urticaria 1
VANCOMYCIN 1.25GM IN 250MLS NORMAL SALINE FRESENIUS KABI USA Neutropenia 1
VANCOMYCIN 1.25GM IN 250MLS NORMAL SALINE FRESENIUS KABI USA Therapy cessation 1
VANCOMYCIN 1.25GM IN 250MLS NORMAL SALINE FRESENIUS KABI USA White blood cell count decreased 1
VANCOMYCIN 1.25GRAM APP Abdominal discomfort 1
VANCOMYCIN 1.25GRAM APP Antibiotic level below therapeutic 1
VANCOMYCIN 1.25GRAM APP Arthralgia 1
VANCOMYCIN 1.25GRAM APP Back pain 1
VANCOMYCIN 100 MG/ML FRESENIUS Abdominal discomfort 1
VANCOMYCIN 100 MG/ML FRESENIUS Drug dose omission 1
VANCOMYCIN 100 MG/ML FRESENIUS Dry mouth 1

Total Records: 1,050     Number of Pages: 53